¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium-losing nephropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® diabetic nephropathy ÇÑ±Û ´ç´¢º´ÄáÆÏº´Áõ
¼³¸í   
  ¿À·¡µÈ ´ç´¢ÀÇ ÇÕº´ÁõÀ¸·Î ¹ß»ýÇÑ´Ù. ´ë°³ ´ç´¢º´¿¡ ÀÌȯµÈ °æ¿ì ´ç´¢º´ ÀÚü¿¡ ÀÇÇÑ Áúº´º¸´Ù ¿À·£ ±â°£ÈÄÀÇ ÇÕº´Áõ¿¡ ÀÇÇØ ¸ñ¼ûÀ» ÀҴ °æ¿ì°¡ ¸¹´Ù. Ãʱ⿡ ´ç´¢º´¿¡¼­ Ç÷Áß Æ÷µµ´ç³óµµ¸¦ Àß Á¶ÀýÇÑ °æ¿ì ÀÌ·± ÇÕº´ÁõÀÌ ¹ß»ýÇϴ °æ¿ì°¡ ³·À¸³ª, ±×·¸Áö ¸øÇÑ °æ¿ì ½ÅÀåÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. Çѹø ¹ß»ýÇÑ °æ¿ì, Ä¡·á´Â ºÒ°¡´ÉÇϸç, ±× ÁøÇà ¶ÇÇÑ ´ÊÃâ ¼ö ¾ø´Ù. Ä¡·á¹ýÀº ¿ÀÁ÷ Çϳª ÄáÆÏÀ̽ļú¿¡ ÀÇÇØ¼­¸¸ °¡´ÉÇϸç À̽ļúÀ» ½ÃÇàÇÑ ÀÌÈÄ¿¡µµ Ç÷´ç·®ÀÇ Á¶ÀýÀº ÇʼöÀûÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´(Áõ), ÁøÅëÁ¦½ÅÀ庴(Áõ)
  • diabetic nephropathy
    ´ç´¢ÄáÆÏº´(Áõ), ´ç´¢½ÅÀ庴(Áõ)
  • gouty nephropathy
    ÅëdzÄáÆÏº´(Áõ), Åëdz½ÅÀ庴(Áõ)
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷ÁõÄáÆÏº´(Áõ), °í¿ä»êÇ÷Áõ½ÅÀ庴(Áõ)
  • IgA nephropathy
    IgAÄáÆÏº´(Áõ), IgA½ÅÀ庴(Áõ)
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´(Áõ), °æ¼â½ÅÀ庴(Áõ)
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´(Áõ), ¸·¼º½ÅÀ庴(Áõ)
  • nephropathy
    ÄáÆÏº´(Áõ), ½ÅÀ庴(Áõ)
  • obstructive nephropathy
    ¸·ÈûÄáÆÏº´(Áõ), Æó¼â½ÅÀ庴(Áõ)
  • reflux nephropathy
    ¿ª·ùÄáÆÏº´(Áõ), ¿ª·ù½ÅÀ庴(Áõ)
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • uric acid nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
  • IgA nephropathy
    ¸é¿ª±Û·Îºí¸°¿¡ÀÌÄáÆÏº´Áõ, ¸é¿ª±Û·Îºí¸°¿¡À̽ÅÀ庴Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • membranous nephropathy
    ¸·¼ºÄáÆÏº´Áõ
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´Áõ
  • uric acid nephropathy
    (¢¡ urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analgesic nephropathy
    ÁøÅëÁ¦ÄáÆÏº´Áõ
  • diabetic nephropathy
    ´ç´¢º´ÄáÆÏº´Áõ
  • gouty nephropathy
    ÅëdzÄáÆÏº´Áõ
  • hyperuricemic nephropathy
    °í´¢»êÇ÷ÁõÄáÆÏº´Áõ
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • membranous nephropathy
    (¢¡glomerulonephritis) Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
  • nephropathy
    ÄáÆÏº´Áõ, ½ÅÀ庴Áõ
  • obstructive nephropathy
    ¸·ÈûÄáÆÏº´Áõ
  • reflux nephropathy
    ¿ª·ùÄáÆÏº´Áõ
  • toxic nephropathy
    µ¶¼ÒÄáÆÏº´Áõ
  • tropical nephropathy
    ¿­´ëÄáÆÏº´Áõ
  • urate nephropathy
    ¿ä»ê¿°ÄáÆÏº´Áõ
  • uric acid nephropathy
    (¢¡urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Balkan nephropathy
    ¹ßÄ­ ½Åº´Áõ
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ(¡­ãìñø)
  • diabetic nephropathy
    ´ç´¢º´(¼º) ½Åº´Áõ.
  • diabetic nephropathy
    ´ç´¢º´¼º ½Åº´Áõ(¡­ãìÜ»ñø)
  • gouty nephropathy
    Åëdz¼º ½Åº´Áõ
  • hyperuricemic nephropathy
    °í¿ä»êÇ÷Áõ¼º ½Åº´Áõ.
  • hyperuricemic nephropathy
    °í´¢»êÇ÷Áõ¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ý¼º ½Åº´Áõ.
  • hypokalemic nephropathy
    ÀúÄ®·ýÇ÷¼º ½Åº´Áõ
  • immunoglobulin a nephropathy
    ¸é¿ª±Û·ÎºÒ¸°A½Åº´Áõ(Øó湡­ãìÜ»ñø)
  • light-chain nephropathy
    °æ¼â ½ÅÁõ(Ìã ãìñø)
  • membranous nephropathy
    ¸·¼º½Åº´Áõ(¡­ãìÜ»ñø)
  • nephropathy
    ½Åº´Áõ,(¡­Ü»ñø), ½ÅÁõ(¡­ñø)
  • obstructive nephropathy
    Æó¼â¼º ½ÅÁúȯ
  • reflux nephropathy
    ¿ª·ù¼º ½Åº´º¯
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
MGN Membranous Glomerulo-Nephritis(Nephropathy)
MN   1) Membranous Nephropathy
  2) Mid-Night; ÀÚÁ¤
AVN acute vasomotor nephropathy; atrioventricular nodal [conduction]; atrioventricular node; avascular n...
DEFN Danubian endemic familial nephropathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AN Analgesic nephropathy
BEN Balcan endemic nephropathy
CHN Chinese herb nephropathy
CAN Chronic allograft nephropathy
DN Diabetic Nephropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • analgesic nephropathy
    ÁøÅëÁ¦Àμº ½Åº´Áõ
  • balkan nephropathy
    ¹ßÄ­ ½ÅÁõ
  • nephropathy
    ½Åº´Áõ, ½ÅÁõ, ½ÅÀ庴Áõ
    ½ÅÀå¿¡ »ý±ä Áúº´.
  • obstructive nephropathy
    Æó¼â¼º ½Å Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
aids-associated nephropathy Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.
(12 Dec 1998)
analgesic nephropathy <nephrology, pathology> A form of kidney damage which can occur from the overexposure to certain analgesics (for example acetaminophen, salicylates and non-steroidal anti-inflammatory agents).
In most cases analgesic use is excessive in dosing or chronicity of use. Complications include acute renal failure.
See: interstitial nephritis.
Origin: Gr. Pathos = disease
(27 Sep 1997)
balkan nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
reflux nephropathy <nephrology> A condition where the chronic backup of urine into a kidney results in kidney damage. Urine is forced out of the bladder and back toward kidney. This condition occurs most commonly in children who have congenital abnormalities of the urinary tract.
Symptoms include back pain, flank, pain, abdominal pain, urinary frequency or urgency and blood in the urine. Other symptoms include nausea, fever and chills, most often indicating a kidney infection has occurred.
Diagnosis is frequently confirmed by voiding cystourethrogram. Surgery is often required to correct the reflux of urine.
Origin: Gr. Pathos = disease
(27 Sep 1997)
membranous nephropathy <pathology> A kidney disease that occurs due to inflammation of the kidney glomerulus and its basement membrane.
The exact cause is unknown but it appears to be related to the deposition of immune complexes in the basement membrane leading to thickening of the capillary walls. This disorder is a common cause of nephrotic syndrome an is usually how the disease manifests.
Risk factors include primary renal disease, malaria, hepatitis B, lupus, syphilis, cancers and non-Hodgkin's lymphomas. Risks also include exposure to some medications such as gold compounds and penicillamine. Mercury, trimethadione and some skin-lightening creams have also been implicated.
Treatment includes systemic corticosteroids and immunosuppressive agents.
(26 Mar 1998)
hereditary deafness and nephropathy <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
Origin: Gr. Pathos = disease
(27 Sep 1997)
hypokalaemic nephropathy Vacuolation of the epithelial cytoplasm of renal convoluted tubules in patients seriously depleted of potassium; vacuoles do not contain fat or glycogen, concentrating ability is impaired, polyuria and polydipsia are common, and pyelonephritis may develop.
Synonym: vacuolar nephrosis.
(05 Mar 2000)
nephropathy <nephrology, urology> Any disease of the kidneys.
Origin: Gr. Pathos = disease
(18 Nov 1997)
Danubian endemic familial nephropathy A tubulointerstitial disease of unknown aetiology occurring in a limited geographic area including adjacent regions of romania, bulgaria, and yugoslavia.
(12 Dec 1998)
diabetic nephropathy <nephrology, pathology> Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function.
Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgA nephropathy <nephrology, pathology> This is a form of glomerulonephritis that results from the deposition of circulating IgA antibody in the kidney tissues.
Inflammation of the glomerulus (glomerulonephritis) is the result. This condition may present as acute glomerulonephritis, chronic glomerulonephritis or rapidly progressive glomerulonephritis.
Berger's is usually detected in an individual with one or two bouts of bloody urine (usually begins during or soon after a respiratory infection) and no other symptoms of renal disease. Only rarely, will Berger's disease permanently affect kidney function and progress to chronic renal failure. This renal disorder more commonly affects males in the 16-40 age group.
Origin: Gr. Pathos = disease
(27 Sep 1997)
IgM nephropathy <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephropathy
    (º´¸®)½ÅÀåÇØ;½ÅÁß;½ÅÀ庴
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á